Table of Contents
ISRN Hematology
Volume 2011 (2011), Article ID 690620, 6 pages
http://dx.doi.org/10.5402/2011/690620
Research Article

The Role of Albumin in Human Toxicology of Cobalt: Contribution from a Clinical Case

1Section of Occupational Health and Industrial Hygiene, Department of Experimental and Applied Medicine, University of Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy
2Department of Public Health and Community Medicine, University of Verona, 37129 Verona, Italy
3Department of Medical and Surgical Sciences, Unit of Neurology, University of Brescia, 25123 Brescia, Italy

Received 27 August 2010; Accepted 21 October 2010

Academic Editor: M. Ohsawa

Copyright © 2011 Simona Catalani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Rizzetti, P. Liberini, G. Zarattini et al., “Loss of sight and sound. Could it be the hip?” The Lancet, vol. 373, no. 9668, p. 1052, 2009. View at Publisher · View at Google Scholar
  2. S. Megaterio, F. Galetto, E. Alossa, and S. Capretto, “Sistemic effects of ionic release in wear of prosthetic head: a case report,” Giorn It Ort Traum, vol. 27, pp. 173–175, 2001. View at Google Scholar
  3. W. Steens, J. F. Loehr, G. Von Foerster, and A. Katzer, “Chronic cobalt poisoning in endoprosthetic replacement,” Orthopade, vol. 35, no. 8, pp. 860–864, 2006. View at Publisher · View at Google Scholar · View at PubMed
  4. M. Oldenburg, R. Wegner, and X. Baur, “Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty,” Journal of Arthroplasty, vol. 24, no. 5, pp. 825–e15, 2009. View at Publisher · View at Google Scholar · View at PubMed
  5. S. S. Tower, “Cobalt toxicity in two hip replacement patients,” Epidemiology Bullettin No. 14, 2010, http://www.epi.alaska.gov/bulletins/docs/b2010_14.pdf.
  6. T. Ikeda, K. Takahashi, T. Kabata, D. Sakagoshi, K. Tomita, and M. Yamada, “Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement,” Muscle and Nerve, vol. 42, no. 1, pp. 140–143, 2010. View at Publisher · View at Google Scholar · View at PubMed
  7. C. Jordan, R. D. Whitman, M. Harbut, and B. Tanner, “Memory deficits in workers suffering from hard metal disease,” Toxicology Letters, vol. 54, no. 2-3, pp. 241–243, 1990. View at Publisher · View at Google Scholar
  8. H. M. Meecham and P. Humphrey, “Industrial exposure to cobalt causing optic atrophy and nerve deafness: a case report,” Journal of Neurology Neurosurgery and Psychiatry, vol. 54, no. 4, pp. 374–375, 1991. View at Google Scholar
  9. F. H. Gardner, “The use of cobaltous chloride in the anemia associated with chronic renal disease,” The Journal of Laboratory and Clinical Medicine, vol. 41, no. 1, pp. 56–64, 1953. View at Google Scholar
  10. U. O. Schirrmacher, “Case of cobalt poisoning,” British Medical Journal, vol. 1, no. 539, pp. 544–545, 1967. View at Google Scholar
  11. A. Licht, M. Oliver, and E. A. Rachmilewitz, “Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow,” Israel Journal of Medical Sciences, vol. 8, no. 1, pp. 61–66, 1972. View at Google Scholar
  12. F. W. Sunderman Jr., S. M. Hopfer, T. Swift et al., “Cobalt, chromium, and nickel concentrations in body fluids of patients with porous-coated knee or hip prostheses,” Journal of Orthopaedic Research, vol. 7, no. 3, pp. 307–315, 1989. View at Google Scholar
  13. P.-A. Vendittoli, M. Ganapathi, and M. Lavigne, “Blood and urine metal ion levels in young and active patients after Birmingham hip resurfacing arthroplasty,” Journal of Bone and Joint Surgery. British, vol. 89, no. 7, p. 989, 2007. View at Publisher · View at Google Scholar · View at PubMed
  14. A. Grübl, M. Marker, W. Brodner et al., “Long-term follow-up of metal-on-metal total hip replacement,” Journal of Orthopaedic Research, vol. 25, no. 7, pp. 841–848, 2007. View at Publisher · View at Google Scholar · View at PubMed
  15. R. F. Coleman, J. Herrington, and J. T. Scales, “Concentration of wear products in hair, blood, and urine after total hip replacement,” British medical journal, vol. 1, no. 5852, pp. 527–529, 1973. View at Google Scholar
  16. C. P. Case, V. G. Langkamer, C. James et al., “Widespread dissemination of metal debris from implants,” Journal of Bone and Joint Surgery. British, vol. 76, no. 5, pp. 701–712, 1994. View at Google Scholar
  17. R. M. Urban, J. J. Jacobs, M. J. Tomlinson, J. Gavrilovic, J. Black, and M. Peoc'h, “Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement,” Journal of Bone and Joint Surgery. American, vol. 82, no. 4, pp. 457–477, 2000. View at Google Scholar
  18. M. S. N. Rao and H. Lal, “Metal protein interactions in buffer solutions. Part II. A polarographic study of the interaction of ZnII and CdII with bovine serum albumin,” Journal of the American Chemical Society, vol. 80, no. 13, pp. 3222–3226, 1958. View at Google Scholar
  19. Y. N. Ordóñez, M. Montes-Bayón, E. Blanco-González et al., “Metal release in patients with total hip arthroplasty by DF-ICP-MS and their association to serum proteins,” Journal of Analytical Atomic Spectrometry, vol. 24, no. 8, pp. 1037–1043, 2009. View at Publisher · View at Google Scholar
  20. D. Bar-Or, L. T. Rael, E. P. Lau et al., “An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species,” Biochemical and Biophysical Research Communications, vol. 284, no. 3, pp. 856–862, 2001. View at Publisher · View at Google Scholar · View at PubMed
  21. G. Lippi, G. Brocco, G. L. Salvagno, M. Montagnana, F. Dima, and G. C. Guidi, “High-workload endurance training may increase serum ischemia-modified albumin concentrations,” Clinical Chemistry and Laboratory Medicine, vol. 43, no. 7, pp. 741–744, 2005. View at Publisher · View at Google Scholar · View at PubMed
  22. G. Lippi, M. Montagnana, G. L. Salvagno, and G. C. Guidi, “Potential value for new diagnostic markers in the early recognition of acute coronary syndromes,” Canadian Journal of Emergency Medicine, vol. 8, no. 1, pp. 27–31, 2006. View at Google Scholar
  23. G. Lippi, M. Montagnana, G. L. Salvagno, and G. C. Guidi, “Standardization of ischemia-modified albumin testing: adjustment for serum albumin,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 2, pp. 261–262, 2007. View at Publisher · View at Google Scholar · View at PubMed
  24. M. Montagnana, G. Lippi, A. Volpe et al., “Evaluation of cardiac laboratory markers in patients with systemic sclerosis,” Clinical Biochemistry, vol. 39, no. 9, pp. 913–917, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. A. Piwowar, M. Knapik-Kordecka, and M. Warwas, “Ischemia-modified albumin level in type 2 diabetes mellitus—preliminary report,” Disease Markers, vol. 24, no. 6, pp. 311–317, 2008. View at Google Scholar
  26. R. Govender, J. De Greef, R. Delport, P. J. Becker, and W. J. H. Vermaak, “Biological variation of ischaemia-modified albumin in healthy subjects,” Cardiovascular Journal of Africa, vol. 19, no. 3, pp. 141–144, 2008. View at Google Scholar
  27. J. M. Sheat, R. J. Peach, and P. M. George, “Rapid detection and initial characterization of genetic variants of human serum albumin,” Clinical Chemistry, vol. 37, no. 7, pp. 1221–1224, 1991. View at Google Scholar
  28. N. V. Bhagavan, E. M. Lai, P. A. Rios et al., “Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction,” Clinical Chemistry, vol. 49, no. 4, pp. 581–585, 2003. View at Publisher · View at Google Scholar
  29. G. De Palma, P. Manini, M. Sarnico, S. Molinari, and P. Apostoli, “Biological monitoring of tungsten (and cobalt) in workers of a hard metal alloy industry,” International Archives of Occupational and Environmental Health, vol. 83, pp. 173–181, 2010. View at Publisher · View at Google Scholar · View at PubMed
  30. P. Apostoli, S. Porru, P. Duca, A. Ferioli, and L. Alessio, “Significance and validity of a shortened lead chelation test,” Journal of Occupational Medicine, vol. 32, no. 11, pp. 1124–1129, 1990. View at Google Scholar
  31. D. Bar-Or, E. Lau, and J. V. Winkler, “A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report,” Journal of Emergency Medicine, vol. 19, no. 4, pp. 311–315, 2000. View at Publisher · View at Google Scholar
  32. D. Bar-Or, L. T. Rael, R. Bar-Or et al., “The cobalt-albumin binding assay: insights into its mode of action,” Clinica Chimica Acta, vol. 387, no. 1-2, pp. 120–127, 2008. View at Publisher · View at Google Scholar · View at PubMed
  33. G. J. Fagan, H. Wayment, D. L. Morris, and P. A. Crosby, “The albumin cobalt binding test: analytical performance of a new automated chemistry assay for the detection of ischemia modified albumin (IMA),” Journal of Clinical Ligand Assay, vol. 25, no. 2, pp. 178–187, 2002. View at Google Scholar
  34. L. R. Walter, E. Marel, R. Harbury, and J. Wearne, “Distribution of chromium and cobalt ions in various blood fractions after resurfacing hip arthroplasty,” Journal of Arthroplasty, vol. 23, no. 6, pp. 814–821, 2008. View at Publisher · View at Google Scholar · View at PubMed
  35. V. Picard, G. Govoni, N. Jabado, and P. Gross, “Nramp 2 (DCT1/DMT1) expressed at the plasma membrane transports iron and other divalent cations into a calcein-accessible cytoplasmic pool,” Journal of Biological Chemistry, vol. 275, no. 46, pp. 35738–35745, 2000. View at Publisher · View at Google Scholar · View at PubMed
  36. J. R. Forbes and P. Gros, “Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane,” Blood, vol. 102, no. 5, pp. 1884–1892, 2003. View at Publisher · View at Google Scholar · View at PubMed
  37. H. Gunshin, B. Mackenzie, U. V. Berger et al., “Cloning and characterization of a mammalian proton-coupled metal-ion transporter,” Nature, vol. 388, no. 6641, pp. 482–488, 1997. View at Publisher · View at Google Scholar · View at PubMed
  38. J. Howitt, U. Putz, J. Lackovic et al., “Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 36, pp. 15489–15494, 2009. View at Publisher · View at Google Scholar · View at PubMed
  39. S. Turedi, A. Gunduz, A. Mentese et al., “Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation,” Resuscitation, vol. 80, no. 9, pp. 994–999, 2009. View at Publisher · View at Google Scholar · View at PubMed
  40. A. Gunduz, S. Turedi, A. Mentese et al., “Ischemia-modified albumin levels in cerebrovascular accidents,” American Journal of Emergency Medicine, vol. 26, no. 8, pp. 874–878, 2008. View at Publisher · View at Google Scholar · View at PubMed
  41. M. Kaefer, S. J. Piva, J. A.M. De Carvalho et al., “Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus,” Clinical Biochemistry, vol. 43, no. 4-5, pp. 450–454, 2010. View at Publisher · View at Google Scholar · View at PubMed
  42. K. Ukinc, S. Eminagaoglu, H. O. Ersoz et al., “A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin,” Endocrine, vol. 36, no. 3, pp. 425–432, 2009. View at Publisher · View at Google Scholar · View at PubMed